Free Trial

Inspire Medical Systems (INSP) Competitors

Inspire Medical Systems logo
$64.08 -2.45 (-3.68%)
Closing price 11/6/2026 03:59 PM Eastern
Extended Trading
$63.98 -0.11 (-0.17%)
As of 11/6/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

INSP vs. TFX, MMED, HAE, LIVN, and ITGR

Should you buy Inspire Medical Systems stock or one of its competitors? Inspire Medical Systems's main competitors and comparable companies include Teleflex (TFX), MiniMed Group (MMED), Haemonetics (HAE), LivaNova (LIVN), and Integer (ITGR). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Inspire Medical Systems compare to Teleflex?

Inspire Medical Systems (NYSE:INSP) and Teleflex (NYSE:TFX) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and risk.

Inspire Medical Systems has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market. Comparatively, Teleflex has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

Teleflex has a net margin of 13.51% compared to Inspire Medical Systems' net margin of 11.43%. Teleflex's return on equity of 10.57% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems11.43% 7.32% 6.39%
Teleflex 13.51%10.57%4.96%

Inspire Medical Systems currently has a consensus price target of $71.24, suggesting a potential upside of 11.16%. Teleflex has a consensus price target of $160.80, suggesting a potential upside of 6.57%. Given Inspire Medical Systems' higher probable upside, equities analysts clearly believe Inspire Medical Systems is more favorable than Teleflex.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10
Teleflex
1 Sell rating(s)
5 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.50

In the previous week, Inspire Medical Systems had 9 more articles in the media than Teleflex. MarketBeat recorded 36 mentions for Inspire Medical Systems and 27 mentions for Teleflex. Inspire Medical Systems' average media sentiment score of 0.69 beat Teleflex's score of 0.59 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
11 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Teleflex
4 Very Positive mention(s)
7 Positive mention(s)
11 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has higher earnings, but lower revenue than Teleflex. Teleflex is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.04$145.42M$3.4418.63
Teleflex$1.99B3.21-$905.64M-$23.29N/A

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 95.6% of Teleflex shares are held by institutional investors. 2.2% of Inspire Medical Systems shares are held by company insiders. Comparatively, 0.7% of Teleflex shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Inspire Medical Systems and Teleflex tied by winning 8 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to MiniMed Group?

Inspire Medical Systems (NYSE:INSP) and MiniMed Group (NASDAQ:MMED) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

94.9% of Inspire Medical Systems shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 0.0% of MiniMed Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Inspire Medical Systems has higher earnings, but lower revenue than MiniMed Group. MiniMed Group is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.04$145.42M$3.4418.63
MiniMed Group$3.10B1.52-$333M-$0.68N/A

Inspire Medical Systems currently has a consensus target price of $71.24, suggesting a potential upside of 11.16%. MiniMed Group has a consensus target price of $24.25, suggesting a potential upside of 45.12%. Given MiniMed Group's stronger consensus rating and higher possible upside, analysts plainly believe MiniMed Group is more favorable than Inspire Medical Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10
MiniMed Group
1 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.68

Inspire Medical Systems has a net margin of 11.43% compared to MiniMed Group's net margin of 0.00%. Inspire Medical Systems' return on equity of 7.32% beat MiniMed Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems11.43% 7.32% 6.39%
MiniMed Group N/A N/A N/A

In the previous week, Inspire Medical Systems had 32 more articles in the media than MiniMed Group. MarketBeat recorded 36 mentions for Inspire Medical Systems and 4 mentions for MiniMed Group. Inspire Medical Systems' average media sentiment score of 0.69 beat MiniMed Group's score of 0.00 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
11 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
MiniMed Group
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Inspire Medical Systems beats MiniMed Group on 12 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Haemonetics?

Inspire Medical Systems (NYSE:INSP) and Haemonetics (NYSE:HAE) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, profitability, media sentiment, institutional ownership, dividends, valuation and risk.

Inspire Medical Systems currently has a consensus target price of $71.24, indicating a potential upside of 11.16%. Haemonetics has a consensus target price of $126.38, indicating a potential upside of 5.43%. Given Inspire Medical Systems' higher probable upside, research analysts clearly believe Inspire Medical Systems is more favorable than Haemonetics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10
Haemonetics
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
2.82

Inspire Medical Systems has higher earnings, but lower revenue than Haemonetics. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspire Medical Systems$911.98M2.04$145.42M$3.4418.63
Haemonetics$1.33B4.09$97.31M$2.0458.76

94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 99.7% of Haemonetics shares are owned by institutional investors. 2.2% of Inspire Medical Systems shares are owned by insiders. Comparatively, 2.1% of Haemonetics shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Inspire Medical Systems has a net margin of 11.43% compared to Haemonetics' net margin of 7.52%. Haemonetics' return on equity of 27.42% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Inspire Medical Systems11.43% 7.32% 6.39%
Haemonetics 7.52%27.42%9.77%

In the previous week, Inspire Medical Systems had 6 more articles in the media than Haemonetics. MarketBeat recorded 36 mentions for Inspire Medical Systems and 30 mentions for Haemonetics. Haemonetics' average media sentiment score of 0.78 beat Inspire Medical Systems' score of 0.69 indicating that Haemonetics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspire Medical Systems
11 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Haemonetics
8 Very Positive mention(s)
7 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Haemonetics has a beta of 0.63, indicating that its stock price is 37% less volatile than the broader market.

Summary

Haemonetics beats Inspire Medical Systems on 9 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, institutional ownership, earnings, media sentiment, profitability and risk.

97.6% of LivaNova shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 0.4% of LivaNova shares are held by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Inspire Medical Systems has lower revenue, but higher earnings than LivaNova. Inspire Medical Systems is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.39B3.57-$242.47M$3.0030.00
Inspire Medical Systems$911.98M2.04$145.42M$3.4418.63

LivaNova has a beta of 0.91, indicating that its stock price is 9% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

LivaNova has a net margin of 13.01% compared to Inspire Medical Systems' net margin of 11.43%. LivaNova's return on equity of 16.10% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
LivaNova13.01% 16.10% 7.85%
Inspire Medical Systems 11.43%7.32%6.39%

In the previous week, Inspire Medical Systems had 12 more articles in the media than LivaNova. MarketBeat recorded 36 mentions for Inspire Medical Systems and 24 mentions for LivaNova. Inspire Medical Systems' average media sentiment score of 0.69 beat LivaNova's score of 0.57 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LivaNova
5 Very Positive mention(s)
3 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
11 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

LivaNova presently has a consensus target price of $99.56, indicating a potential upside of 10.63%. Inspire Medical Systems has a consensus target price of $71.24, indicating a potential upside of 11.16%. Given Inspire Medical Systems' higher probable upside, analysts clearly believe Inspire Medical Systems is more favorable than LivaNova.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LivaNova
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10

Summary

LivaNova beats Inspire Medical Systems on 10 of the 16 factors compared between the two stocks.

How does Inspire Medical Systems compare to Integer?

Integer (NYSE:ITGR) and Inspire Medical Systems (NYSE:INSP) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, institutional ownership, valuation, earnings, risk, profitability and dividends.

99.3% of Integer shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 1.1% of Integer shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Integer has a beta of 0.6, indicating that its share price is 40% less volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Integer currently has a consensus price target of $113.67, indicating a potential downside of 10.21%. Inspire Medical Systems has a consensus price target of $71.24, indicating a potential upside of 11.16%. Given Inspire Medical Systems' stronger consensus rating and higher probable upside, analysts plainly believe Inspire Medical Systems is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Integer
0 Sell rating(s)
11 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.08
Inspire Medical Systems
3 Sell rating(s)
13 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.10

In the previous week, Inspire Medical Systems had 33 more articles in the media than Integer. MarketBeat recorded 36 mentions for Inspire Medical Systems and 3 mentions for Integer. Inspire Medical Systems' average media sentiment score of 0.69 beat Integer's score of 0.56 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Integer
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspire Medical Systems
11 Very Positive mention(s)
5 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspire Medical Systems has a net margin of 11.43% compared to Integer's net margin of 5.68%. Integer's return on equity of 11.84% beat Inspire Medical Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Integer5.68% 11.84% 5.98%
Inspire Medical Systems 11.43%7.32%6.39%

Inspire Medical Systems has lower revenue, but higher earnings than Integer. Inspire Medical Systems is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Integer$1.83B2.36$102.81M$2.9842.48
Inspire Medical Systems$911.98M2.04$145.42M$3.4418.63

Summary

Inspire Medical Systems beats Integer on 12 of the 17 factors compared between the two stocks.

Get Inspire Medical Systems News Delivered to You Automatically

Sign up to receive the latest news and ratings for INSP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INSP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INSP vs. The Competition

MetricInspire Medical SystemsHealthcare Equipment & Supplies IndustryHealthcare SectorNYSE Exchange
Market Cap$1.85B$6.15B$7.76B$22.98B
Dividend YieldN/A1.68%2.47%3.76%
P/E Ratio18.6337.8334.4929.91
Price / Sales2.115.378.153.36
Price / Cash22.3423.1721.8215.54
Price / Book2.244.694.533.77
Net Income$145.42M$147.03M$3.51B$1.08B
7 Day Performance-5.79%-0.25%-1.01%-0.92%
1 Month Performance-3.64%-1.31%-4.45%-0.66%
1 Year Performance-21.51%3.29%2.63%6.01%

Inspire Medical Systems Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INSP
Inspire Medical Systems
3.3538 of 5 stars
$64.08
-3.7%
$71.24
+11.2%
-21.5%$1.85B$880.94M18.631,333
TFX
Teleflex
3.5743 of 5 stars
$140.54
+0.6%
$154.40
+9.9%
+37.9%$5.89B$1.99B15.8815,500
MMED
MiniMed Group
1.7722 of 5 stars
$18.90
+3.4%
$24.25
+28.3%
N/A$5.40B$3.10BN/A2,800
HAE
Haemonetics
2.4026 of 5 stars
$120.15
+0.4%
$110.00
-8.5%
+74.5%$5.38B$1.33B23.623,009
LIVN
LivaNova
2.7233 of 5 stars
$80.21
+1.6%
$87.75
+9.4%
+78.4%$4.44B$1.39B23.733,300

Related Companies and Tools


This page (NYSE:INSP) was last updated on 11/8/2026 by MarketBeat.com Staff.
From Our Partners